Joel Greenblatt acquired 44.4 Thousand Abbvie shares worth $7.46 Million. That's 0.13% of their equity portfolio (176th largest holding). The first Abbvie trade was made in Q1 2013. Since then Joel Greenblatt bought shares 21 more times and sold shares on 22 occasions. The stake costed the investor $3.01 Million, netting the investor a gain of 148% so far.